Lung Fibrosis
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pulmonary Fibrosis Foundation Community Registry (NCT05382572) | Pulmonary Fibrosis Foundation | 2022-07-11 |
| Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis (NCT05648734) | Mansoura University | 2022-03-10 |
| Immune Modulation by Exosomes in COVID-19 (NCT05191381) | University of Ulm | 2021-12-22 |
| A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis (NCT04274257) | Tokyo University | 2017-12-04 |
| Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease (NCT01570764) | Assistance Publique - Hôpitaux de Paris | 2013-01-14 |
Track Lung Fibrosis automatically
Every clearance here is in the API, with alerts when new ones post.